Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: Implications for the use of antiresorptive agents in the old and oldest old
Autores:El-Hajj Fuleihan, G., Barton, I.P., Delmas, P., Steven Boonen, McClung, M.R., Eastell, R.